Plunkett Matthew

EVP, Chief Business Officer at CELL THERAPEUTICS INC

Sold, on record
$1.8M
Dollars the filings state
Form 4 sales
28
Latest Mar 4, 2016
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale CELL THERAPEUTICS INCUnusual
    Sep 24, 2015 2015

    Sold 75,869 shares at $1.57 ($119k)

    Plunkett Matthew, EVP, Corporate Development

    Sold 9.5% of holdings ($1.3M position)725,084 shares left6.3x usual sizeFiling

  2. 2 Form 4 sale CELL THERAPEUTICS INCUnusual
    Sep 29, 2015 +5 days

    Sold 75,000 shares at $1.41 ($106k)

    Plunkett Matthew, EVP, Corporate Development

    Sold 10.3% of holdings ($1M position)650,084 shares left6.3x usual sizeFiling

  3. 3 Form 4 sale CELL THERAPEUTICS INCPlan not stated
    Oct 5, 2015 +6 days

    Sold 10,000 shares at $1.52 ($15k)

    Plunkett Matthew, EVP, Corporate Development

    Sold 1.5% of holdings ($989k position)640,084 shares left0.8x usual sizeFiling

  4. 4 Form 4 sale CELL THERAPEUTICS INCPlan not stated
    Nov 4, 2015 +30 days

    Sold 10,000 shares at $1.38 ($14k)

    Plunkett Matthew, EVP, Corporate Development

    Sold 1.6% of holdings ($885k position)630,084 shares left0.8x usual sizeFiling

  5. 5 Form 4 sale CELL THERAPEUTICS INCPlan not stated
    Dec 4, 2015 +30 days

    Sold 10,000 shares at $1.00 ($10k)

    Plunkett Matthew, EVP, Corporate Development

    Sold 1.6% of holdings ($628k position)620,084 shares left0.8x usual sizeFiling

  6. 6 Form 4 sale CELL THERAPEUTICS INCPlan not stated
    Jan 4, 2016 +31 days

    Sold 10,000 shares at $1.21 ($12k)

    Plunkett Matthew, EVP, Chief Business Officer

    Sold 1.6% of holdings ($753k position)610,084 shares left0.8x usual sizeFiling

  7. 7 Form 4 sale CELL THERAPEUTICS INCPlan not stated
    Feb 4, 2016 +31 days

    Sold 10,000 shares at $1.16 ($12k)

    Plunkett Matthew, EVP, Chief Business Officer

    Sold 1.6% of holdings ($705k position)600,084 shares left0.8x usual sizeFiling

  8. 8 Form 4 sale CELL THERAPEUTICS INCPlan not stated
    Mar 4, 2016 +29 days

    Sold 10,000 shares at $0.59 ($6k)

    Plunkett Matthew, EVP, Chief Business Officer

    Sold 1.7% of holdings ($355k position)590,084 shares left0.8x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (28)

Form 144 notices and Form 4 sales by Plunkett Matthew
Source
Mar 4, 2016Mar 4, 2016CELL THERAPEUTICS INCEVP, Chief Business OfficerForm 4 sale10,000$6k1.7%Plan not statedSEC
Feb 4, 2016Feb 5, 2016CELL THERAPEUTICS INCEVP, Chief Business OfficerForm 4 sale10,000$12k1.6%Plan not statedSEC
Jan 4, 2016Jan 6, 2016CELL THERAPEUTICS INCEVP, Chief Business OfficerForm 4 sale10,000$12k1.6%Plan not statedSEC
Dec 4, 2015Dec 4, 2015CELL THERAPEUTICS INCEVP, Corporate DevelopmentForm 4 sale10,000$10k1.6%Plan not statedSEC
Nov 4, 2015Nov 6, 2015CELL THERAPEUTICS INCEVP, Corporate DevelopmentForm 4 sale10,000$14k1.6%Plan not statedSEC
Oct 5, 2015Oct 7, 2015CELL THERAPEUTICS INCEVP, Corporate DevelopmentForm 4 sale10,000$15k1.5%Plan not statedSEC
Sep 29, 2015Oct 1, 2015CELL THERAPEUTICS INCEVP, Corporate DevelopmentForm 4 sale75,000$106k10.3%UnusualSEC
Sep 24, 2015Sep 25, 2015CELL THERAPEUTICS INCEVP, Corporate DevelopmentForm 4 sale75,869$119k9.5%UnusualSEC
Sep 4, 2015Sep 4, 2015CELL THERAPEUTICS INCEVP, Corporate DevelopmentForm 4 sale10,000$15k1.5%Plan not statedSEC
Aug 4, 2015Aug 6, 2015CELL THERAPEUTICS INCEVP, Corporate DevelopmentForm 4 sale10,000$18k1.5%Plan not statedSEC
Jul 6, 2015Jul 8, 2015CELL THERAPEUTICS INCEVP, Corporate DevelopmentForm 4 sale10,000$20k1.4%Plan not statedSEC
Jun 4, 2015Jun 5, 2015CELL THERAPEUTICS INCEVP, Corporate DevelopmentForm 4 sale10,000$21k1.4%Plan not statedSEC
May 4, 2015May 4, 2015CELL THERAPEUTICS INCEVP, Corporate DevelopmentForm 4 sale10,000$19k1.4%Plan not statedSEC
Apr 6, 2015Apr 8, 2015CELL THERAPEUTICS INCEVP, Corporate DevelopmentForm 4 sale16,569$31k2.3%Plan not statedSEC
Mar 23, 2015Mar 24, 2015CELL THERAPEUTICS INCEVP, Corporate DevelopmentForm 4 sale59,130$116k7.5%UnusualSEC
Mar 4, 2015Mar 6, 2015CELL THERAPEUTICS INCEVP, Corporate DevelopmentForm 4 sale12,000$29k1.4%Plan not statedSEC
Feb 4, 2015Feb 6, 2015CELL THERAPEUTICS INCEVP, Corporate DevelopmentForm 4 sale12,000$27k1.4%Plan not statedSEC
Jan 5, 2015Jan 7, 2015CELL THERAPEUTICS INCEVP, Corporate DevelopmentForm 4 sale12,000$28k3.0%Plan not statedSEC
Dec 4, 2014Dec 5, 2014CELL THERAPEUTICS INCEVP, Corporate DevelopmentForm 4 sale12,000$27k2.9%Plan not statedSEC
Nov 4, 2014Nov 6, 2014CELL THERAPEUTICS INCEVP, Corporate DevelopmentForm 4 sale12,000$29k2.8%Plan not statedSEC
Oct 6, 2014Oct 8, 2014CELL THERAPEUTICS INCEVP, Corporate DevelopmentForm 4 sale12,000$29k2.7%Plan not statedSEC
Sep 23, 2014Sep 24, 2014CELL THERAPEUTICS INCEVP, Corporate DevelopmentForm 4 sale103,635$265k19.0%UnusualSEC
Sep 4, 2014Sep 5, 2014CELL THERAPEUTICS INCEVP, Corporate DevelopmentForm 4 sale27,301$68k4.8%Plan not statedSEC
Aug 4, 2014Aug 6, 2014CELL THERAPEUTICS INCEVP, Corporate DevelopmentForm 4 sale12,000$30k2.1%Plan not statedSEC
Jul 7, 2014Jul 9, 2014CELL THERAPEUTICS INCEVP, Corporate DevelopmentForm 4 sale12,000$35k2.0%Plan not statedSEC
Jun 4, 2014Jun 6, 2014CELL THERAPEUTICS INCEVP, Corporate DevelopmentForm 4 sale12,000$36k2.0%Plan not statedSEC
May 5, 2014May 7, 2014CELL THERAPEUTICS INCEVP, Corporate DevelopmentForm 4 sale12,000$36k1.9%Plan not statedSEC
Mar 21, 2014Mar 21, 2014CELL THERAPEUTICS INCEVP, Corporate DevelopmentForm 4 sale170,000$634k21.5%Plan not statedSEC